Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Investigation Into McClellan Plan B Memos Sought By House Democrats

This article was originally published in The Tan Sheet

Executive Summary

The GAO investigation into FDA's decision-making process that led to the Plan B switch rejection has raised questions as to whether FDA violated federal records management laws

You may also be interested in...



“New” Plan B Emails Say FDA’s “Novel” Concerns Were Not Novel – Waxman

Internal emails suggest FDA began addressing legal issues pertaining to "dual marketing" of Plan B in early 2004; these documents could strengthen the Center for Reproductive Rights' suit against the agency over the delay in considering OTC status for the drug

“New” Plan B Emails Say FDA’s “Novel” Concerns Were Not Novel – Waxman

Internal emails suggest FDA began addressing legal issues pertaining to "dual marketing" of Plan B in early 2004; these documents could strengthen the Center for Reproductive Rights' suit against the agency over the delay in considering OTC status for the drug

“New” Plan B Emails Say FDA’s “Novel” Concerns Were Not Novel – Waxman

Internal emails suggest FDA began addressing legal issues pertaining to "dual marketing" of Plan B in early 2004; these documents could strengthen the Center for Reproductive Rights' suit against the agency over the delay in considering OTC status for the drug

Topics

UsernamePublicRestriction

Register

PS098844

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel